Morten Krogh Jensen

967 total citations
24 papers, 717 citations indexed

About

Morten Krogh Jensen is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Morten Krogh Jensen has authored 24 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Hematology and 7 papers in Oncology. Recurrent topics in Morten Krogh Jensen's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Eosinophilic Disorders and Syndromes (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Morten Krogh Jensen is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Eosinophilic Disorders and Syndromes (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Morten Krogh Jensen collaborates with scholars based in Denmark, United States and Sweden. Morten Krogh Jensen's co-authors include Hans Carl Hasselbalch, Ove Juul Nielsen, Peter de Nully Brown, I. Prange, Caroline Hasselbalch Riley, Inger Kruse, Hans G. Dam, Inge Marie Svane, B. Lund and Per thor Straten and has published in prestigious journals such as Blood, American Journal Of Pathology and British Journal of Haematology.

In The Last Decade

Morten Krogh Jensen

24 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morten Krogh Jensen Denmark 15 315 312 161 161 153 24 717
Muhammad Shurafa United States 12 262 0.8× 420 1.3× 319 2.0× 46 0.3× 271 1.8× 29 912
Joseph P. Abraham United States 11 215 0.7× 250 0.8× 65 0.4× 68 0.4× 129 0.8× 19 601
Dong Soon Lee South Korea 18 252 0.8× 575 1.8× 203 1.3× 74 0.5× 329 2.2× 75 882
Nicole A. Carreau United States 9 150 0.5× 410 1.3× 159 1.0× 52 0.3× 157 1.0× 12 677
Radovan Vrḫovac Croatia 15 330 1.0× 243 0.8× 253 1.6× 65 0.4× 223 1.5× 65 810
Mario Annunziata Italy 17 255 0.8× 592 1.9× 141 0.9× 108 0.7× 202 1.3× 51 776
Ik‐Chan Song South Korea 17 97 0.3× 237 0.8× 208 1.3× 62 0.4× 236 1.5× 87 720
Francisca Ferrer‐Marín Spain 20 572 1.8× 731 2.3× 60 0.4× 267 1.7× 374 2.4× 66 1.2k
Jacek Treliński Poland 12 206 0.7× 394 1.3× 41 0.3× 58 0.4× 115 0.8× 50 639
M. Cazzola Italy 12 505 1.6× 639 2.0× 70 0.4× 90 0.6× 102 0.7× 17 801

Countries citing papers authored by Morten Krogh Jensen

Since Specialization
Citations

This map shows the geographic impact of Morten Krogh Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Krogh Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Krogh Jensen more than expected).

Fields of papers citing papers by Morten Krogh Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Krogh Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Krogh Jensen. The network helps show where Morten Krogh Jensen may publish in the future.

Co-authorship network of co-authors of Morten Krogh Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Krogh Jensen. A scholar is included among the top collaborators of Morten Krogh Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Krogh Jensen. Morten Krogh Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Østgård, Lene Sofie Granfeldt, Mette Nørgaard, Henrik Sengeløv, et al.. (2016). Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients. Oncotarget. 7(44). 72044–72056. 13 indexed citations
2.
Riley, Caroline Hasselbalch, Marie K. Brimnes, Morten Hansen, et al.. (2015). Interferon‐α induces marked alterations in circulating regulatory T cells, NK cell subsets, and dendritic cells in patients with JAK2V617F‐positive essential thrombocythemia and polycythemia vera. European Journal Of Haematology. 97(1). 83–92. 27 indexed citations
3.
Bjørn, Mads Emil, Christen Lykkegaard Andersen, Morten Krogh Jensen, & Hans Carl Hasselbalch. (2014). Circulating YKL‐40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state. European Journal Of Haematology. 93(3). 224–228. 21 indexed citations
4.
Gudbrandsdottir, Sif, Henrik Birgens, Henrik Frederiksen, et al.. (2013). Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia. Blood. 121(11). 1976–1981. 125 indexed citations
5.
Bender, Brendan C., et al.. (2012). Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia. Cancer Chemotherapy and Pharmacology. 69(5). 1155–1163. 28 indexed citations
6.
Hasselbalch, Hans Carl, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, Morten Krogh Jensen, & Jean‐Jacques Kiladjian. (2011). Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives. Current Drug Targets. 12(3). 392–419. 29 indexed citations
7.
Skov, Vibe, Thomas Stauffer Larsen, Mads Thomassen, et al.. (2010). Enhanced Gene Expression of EZH2 In Patients with Primary Myelofibrosis. Blood. 116(21). 4118–4118. 1 indexed citations
8.
9.
Jensen, Morten Krogh, Mads Holten-Andersen, Rikke Riisbro, et al.. (2003). Elevated plasma levels of TIMP‐1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disorders. European Journal Of Haematology. 71(5). 377–384. 17 indexed citations
10.
Jensen, Morten Krogh, Rikke Riisbro, Peter de Nully Brown, Nils Brünner, & Hans Carl Hasselbalch. (2002). Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera. European Journal Of Haematology. 69(1). 43–49. 12 indexed citations
11.
Fusté, Berta, Maribel Díaz‐Ricart, Morten Krogh Jensen, et al.. (2002). TRAP Induces More Intense Tyrosine Phosphorylation than Thrombin with Differential Ultrastructural Features. American Journal Of Pathology. 160(6). 2245–2252. 12 indexed citations
12.
Jensen, Morten Krogh, Peter de Nully Brown, Sixtus Thorsen, & Hans Carl Hasselbalch. (2002). Frequent occurrence of anticardiolipin antibodies, Factor V Leiden mutation, and perturbed endothelial function in chronic myeloproliferative disorders. American Journal of Hematology. 69(3). 185–191. 26 indexed citations
13.
Jensen, Morten Krogh, Peter de Nully Brown, B. Lund, Ove Juul Nielsen, & Hans Carl Hasselbalch. (2000). Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders. British Journal of Haematology. 110(1). 116–124. 82 indexed citations
14.
Jensen, Morten Krogh, et al.. (1997). EBV-Positive Primary Central Nervous System Lymphomas in Monozygote Twins with Common Variable Immunodeficiency and Suspected Multiple Sclerosis. Leukemia & lymphoma. 28(1-2). 187–193. 7 indexed citations
15.
Jensen, Morten Krogh, et al.. (1996). Suspected Malignant Lymphoma Presenting with Widespread Granulomatous Lesions in Bones and Lymph Nodes and Responding to Combination Chemotherapy. Acta Haematologica. 96(4). 237–241. 4 indexed citations
16.
Dam, Hans G., et al.. (1975). Studies of human bile. Zeitschrift für Ernährungswissenschaft. 14(1). 1–17. 2 indexed citations
17.
Dam, Henrik, et al.. (1971). Studies on human bile. Zeitschrift für Ernährungswissenschaft. 10(3). 178–187. 59 indexed citations
18.
Dam, Hans G., et al.. (1971). Studies on human bile. Zeitschrift für Ernährungswissenschaft. 10(3). 160–177. 47 indexed citations
19.
Dam, Henrik, et al.. (1971). Studies on human bile. Zeitschrift für Ernährungswissenschaft. 10(3). 188–197. 16 indexed citations
20.
Dam, Hans G., et al.. (1966). Studies on Human Rile. Scandinavian Journal of Clinical and Laboratory Investigation. 18(4). 385–404. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Shurafa Breakdown of academic impact, for papers by Joseph P. Abraham Breakdown of academic impact, for papers by Dong Soon Lee Breakdown of academic impact, for papers by Nicole A. Carreau Breakdown of academic impact, for papers by Radovan Vrḫovac Breakdown of academic impact, for papers by Mario Annunziata Breakdown of academic impact, for papers by Ik‐Chan Song Breakdown of academic impact, for papers by Francisca Ferrer‐Marín Breakdown of academic impact, for papers by Jacek Treliński Breakdown of academic impact, for papers by M. Cazzola
Rankless by CCL
2026